Van Andel Institute
New research from the Grand Rapids-based Van Andel Research Institute demonstrates on the molecular level how the anti-malaria drug chloroquine represses inflammation, which may provide a blueprint for new strategies for treating auto-immune diseases from […]
The Neuroblastoma and Medulloblastoma Translational Research Consortium Tuesday announced the opening of a first-of-its-kind genomic-based clinical trial to treat and study pediatric cancer — specifically relapsed and refractory neuroblastoma, a deadly tumor that forms around nerve cells in children.
Grand Rapids is Michigan’s second largest city with a technology sector that’s huge and thriving, so it’s always easy to find something new when the Great Lakes Innovation and Technology Report rolls into town.
Top executives at the Grand Rapids-based Van Andel Research Institute Tuesday announced the creation of the VARI Pediatric Cancer Translational Research Program, which will unite basic research and clinical care through a nationwide consortium of partners.